My HPRA: Register

Methotrexate - Important Safety Information from the Marketing Authorisation Holders of products containing Methotrexate as approved by the HPRA

Notice type: 3rd Party Publications

Date: 02/12/2019

  

Problem Or Issue:
Important Safety Information communication from the marketing authorisation holders of products containing Methotrexate on recommendations to avoid potentially fatal dosing errors when using Methotrexate for inflammatory diseases

Methotrexate - Important Safety Information from the Marketing Authorisation Holders of products containing Methotrexate as approved by the HPRA

« Back